flixotide evohaler 125 mikrogram/dos inhalationsspray, suspension
cross pharma ab - flutikasonpropionat - inhalationsspray, suspension - 125 mikrogram/dos - flutikasonpropionat 125 mikrog aktiv substans - flutikason
flixotide evohaler 50 mikrogram/dos inhalationsspray, suspension
orifarm ab - flutikasonpropionat - inhalationsspray, suspension - 50 mikrogram/dos - flutikasonpropionat 50 mikrog aktiv substans - flutikason
flixotide evohaler 50 mikrogram/dos inhalationsspray, suspension
orifarm ab - flutikasonpropionat - inhalationsspray, suspension - 50 mikrogram/dos - flutikasonpropionat 50 mikrog aktiv substans - flutikason
norprolac 25 mikrogram + 50 mikrogram tablett
ferring läkemedel ab - kinagolidhydroklorid - tablett - 25 mikrogram + 50 mikrogram - kinagolidhydroklorid 27 mikrog aktiv substans; laktosmonohydrat hjälpämne; kinagolidhydroklorid 55 mikrog aktiv substans; laktosmonohydrat hjälpämne - kinagolid
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pulmonell sjukdom, kronisk obstruktiv - läkemedel mot obstruktiv lungsjukdom, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pulmonell sjukdom, kronisk obstruktiv - läkemedel mot obstruktiv lungsjukdom, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
ondansetron hexal 2 mg/ml injektionsvätska, lösning
hexal a/s - ondansetronhydrokloriddihydrat - injektionsvätska, lösning - 2 mg/ml - ondansetronhydrokloriddihydrat 2,494 mg aktiv substans - ondansetron
ondansetron teva 4 mg filmdragerad tablett
teva sweden ab - ondansetronhydrokloriddihydrat - filmdragerad tablett - 4 mg - laktosmonohydrat hjälpämne; ondansetronhydrokloriddihydrat 5 mg aktiv substans - ondansetron
ondansetron teva 8 mg filmdragerad tablett
teva sweden ab - ondansetronhydrokloriddihydrat - filmdragerad tablett - 8 mg - ondansetronhydrokloriddihydrat 10 mg aktiv substans; laktosmonohydrat hjälpämne - ondansetron
adasuve
ferrer internacional s.a. - loxapin - schizophrenia; bipolar disorder - nervsystem - adasuve är indicerat för snabb kontroll av mild till moderat agitation hos vuxna patienter med schizofreni eller bipolär sjukdom. patienter bör få regelbunden behandling omedelbart efter kontroll av akut agitation symptom.